Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/8/21 16:15 | 5/8/20 | AYLA | Health | BioPrd | Biological Products, (No Diag | Sidransky David | L3 | D | P.m | 4 | 14.80 | 0 | 0 | New | 0 | I | |||||||||||||||
5/14/20 20:30 | 5/12/20 | AYLA | Health | BioPrd | Biological Products, (No Diag | Harel Insurance Co Ltd | L3 | T | P.d | 8,250 | 15.00 | 0 | 550 | 34 | 2,164 | I | |||||||||||||||
5/14/20 16:41 | 5/12/20 | AYLA | Health | BioPrd | Biological Products, (No Diag | Israel Biotech Fund I, L.P. | E9 | T | P.d | 3,375 | 15.00 | 0 | 225 | 7 | 3,315 | D | |||||||||||||||
5/14/20 16:31 | 5/12/20 | AYLA | Health | BioPrd | Biological Products, (No Diag | Amoon 2 Fund Limited Partnership | L3 | T | P.d | 12,000 | 15.00 | 0 | 800 | 37 | 2,991 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |